Wasatch Advisors’s Denali Therapeutics DNLI Stock Holding History

Wasatch Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-238,881	Closed	-$6.96M	–	238
2024 Q3	$6.96M	Sell	238,881 -163,528	-41%	-$4.76M	0.03%	183
2024 Q2	$9.34M	Sell	402,409 -261	-0.1%	-$6.06K	0.05%	156
2024 Q1	$8.26M	Buy	402,670 +90,369	+29%	+$1.85M	0.04%	174
2023 Q4	$6.7M	Sell	312,301 -9,166	-3%	-$197K	0.04%	181
2023 Q3	$6.63M	Sell	321,467 -510,830	-61%	-$10.5M	0.04%	175
2023 Q2	$24.6M	Buy	832,297 +274,130	+49%	+$8.09M	0.15%	113
2023 Q1	$12.9M	Buy	558,167 +107,217	+24%	+$2.47M	0.08%	150
2022 Q4	$12.5M	Buy	450,950 +91,477	+25%	+$2.54M	0.08%	157
2022 Q3	$11M	Buy	359,473 +17,799	+5%	+$546K	0.08%	166
2022 Q2	$10.1M	Buy	341,674 +104,251	+44%	+$3.07M	0.06%	170
2022 Q1	$7.64M	Buy	237,423 +63,181	+36%	+$2.03M	0.04%	201
2021 Q4	$7.77M	Sell	174,242 -286	-0.2%	-$12.8K	0.03%	215
2021 Q3	$8.81M	Sell	174,528 -362,718	-68%	-$18.3M	0.04%	216
2021 Q2	$42.1M	Buy	537,246 +58,804	+12%	+$4.61M	0.17%	118
2021 Q1	$27.3M	Sell	478,442 -2,842	-0.6%	-$162K	0.12%	144
2020 Q4	$40.3M	Sell	481,284 -853,901	-64%	-$71.5M	0.2%	104
2020 Q3	$47.8M	Buy	1,335,185 +131,775	+11%	+$4.72M	0.3%	94
2020 Q2	$29.1M	Buy	1,203,410 +63,153	+6%	+$1.53M	0.21%	110
2020 Q1	$20M	Buy	1,140,257 +83,411	+8%	+$1.46M	0.21%	96
2019 Q4	$18.4M	Buy	1,056,846 +79,185	+8%	+$1.38M	0.15%	114
2019 Q3	$15M	Sell	977,661 -18,486	-2%	-$283K	0.14%	116
2019 Q2	$20.7M	Buy	996,147 +175,243	+21%	+$3.64M	0.2%	101
2019 Q1	$19.1M	Buy	820,904 +775,358	+1,702%	+$18M	0.21%	88
2018 Q4	$941K	Sell	45,546 -13,723	-23%	-$284K	0.01%	222
2018 Q3	$1.29M	Buy	59,269 +28,138	+90%	+$612K	0.01%	226
2018 Q2	$475K	Hold	31,131	–	–	0.01%	270
2018 Q1	$613K	Hold	31,131	–	–	0.01%	268
2017 Q4	$487K	Buy	+31,131	New	+$487K	0.01%	280